This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.

After debating it for what seemed forever, I finally decided to do it! Figured Gilenya is an acceptable option right now. Far from perfect, but still acceptable. Worrying about side effects (increased risk of cancer and liver problems, even PML) will probably never go away, but my mind is made up for now. Will follow closely reports of adverse effects and reevaluate each time. Just have to remind myself that it is not a forever ...

Novartis announced today findings from an international multiple sclerosis (MS) registry and a US health claims data base which showed the real-world superiority of Gilenya® (fingolimod) in reducing risks of relapses compared to standard therapies. These data confirm the positive results seen in clinical trials with Gilenya, and were presented at the ongoing 29th Congress of the European Committee for Treatment and ...

Twelve years ago my mother came down with MS. The nescience about this theme has really employed me. That’s why I decided to make my work for general qualification for university entrance about this interesting issue.I’m conscious of not-being the first guy who wants to do this and I’m also not the last one. However I would be really thankful if you would take just five or ten minutes to answer to ...

Novartis International AG has announced that new data showing the benefits of Gilenya on patient outcomes in multiple sclerosis will be presented at the 29th Congress of the European Committee for Research and Treatment in Multiple Sclerosis in Copenhagen, Denmark..... Read More - http://www.ms-uk.org/gilenya

This is much of a post on another forum. Please forgive me if you read it twice.

I took Copaxone EOD for the past year or so. It was not what was recommended by the doc but I just decided that every day was just too much. Of course, if I had believed Copax would make a huge difference I would have felt differentlly. But for 30% reduction in relapses... I figured I would take ...

i was reading about the mechanism by which gilenya works-- trapping white blood cells in the lymph nodes. also that gilenya reduces your ability to fight infections... does this mean that if i take gilenya i am immune compromised? has anyone had a problem with infections, colds, or viruses increasing after taking gilenya?

A patient taking Novartis' multiple sclerosis pill Gilenya developed a rare and potentially fatal viral disease, the Swiss drugmaker said on Tuesday, an unexpected setback as it faces growing competition from new oral treatments.

Gilenya is one of Novartis' big new drug hopes, growing 66 percent in the second quarter to $468 million. But the drug faces competition from new medicines such as Biogen Idec's Tecfidera....... Read More - http://www.ms-uk.org/index.cfm/gilenya

At our last conversation in March, my neurologist opened up the universe of MS drugs for me to choose one, including Tysabri. That was a surprise. I had been gritting my teeth getting ready to reluctantly submit to Avonex. I took a week to think. I read trial results for Gilenya, especially the brain atrophy result and decided to add Gilenya while I can still afford health insurance. If it goes poorly I can ...

The Swiss drug maker Novartis is taking a sassy new tack to win converts to its oral multiple sclerosis treatment, Gilenya. Its “Hey MS, Take This!” campaign shows patients sticking out their tongues with Gilenya capsules on them to show their willingness to fight back against the neurological condition..... Read More - http://www.ms-uk.org/index.cfm/MSnews

Data presented at the 65th annual meeting of the American Academy of Neurology (AAN) show Gilenya® (fingolimod), the first and only once-daily oral therapy reimbursed to treat highly active relapsing-remitting multiple sclerosis (RRMS), significantly and consistently reduced the rate of brain volume loss and reduced relapse rates compared to interferon beta-1a IM or placebo.

Statistics

This site does not offer, or claim to offer, medical, legal, or professional advice.
All treatment decisions should always be made with the full knowledge of your physicians.
This is MS does not create, endorse, or republish any content.
All postings are the responsibility of the poster. All logos and trademarks in this site are property of their respective owners. All users must respect our rules for intellectual property rights.